Meyka AI API is live for developers.Start building.
Advertisement
Marpai, Inc.

Marpai, Inc. Fundamental Analysis

MRAINASDAQ
HealthcareMedical - Healthcare Plans
$0.57
$0.010(1.79%)
U.S. Market opens in 52h 31m
Advertisement

Marpai, Inc. Fundamental Analysis

Marpai, Inc. (MRAI) shows moderate financial fundamentals with a PE ratio of -0.98, profit margin of -97.37%, and ROE of 49.95%. The company generates $0.0B in annual revenue with weak year-over-year growth of -35.76%.

Key Strengths

ROE49.95%
PEG Ratio-0.02

Areas of Concern

Operating Margin-80.40%
Cash Position1.43%
Current Ratio0.38
We analyze MRAI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -67.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-67.1/100

We analyze MRAI's fundamental strength across five key dimensions:

Efficiency Score

Weak

MRAI struggles to generate sufficient returns from assets.

ROA > 10%
-1.53%

Valuation Score

Excellent

MRAI trades at attractive valuation levels.

PE < 25
-0.98
PEG Ratio < 2
-0.02

Growth Score

Moderate

MRAI shows steady but slowing expansion.

Revenue Growth > 5%
-35.76%
EPS Growth > 10%
50.52%

Financial Health Score

Moderate

MRAI shows balanced financial health with some risks.

Debt/Equity < 1
-0.02
Current Ratio > 1
0.38

Profitability Score

Weak

MRAI struggles to sustain strong margins.

ROE > 15%
49.95%
Net Margin ≥ 15%
-97.37%
Positive Free Cash Flow
No

Key Financial Metrics

Is MRAI Expensive or Cheap?

P/E Ratio

MRAI trades at -0.98 times earnings. This suggests potential undervaluation.

-0.98

PEG Ratio

When adjusting for growth, MRAI's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Marpai, Inc. at -0.46 times its book value. This may indicate undervaluation.

-0.46

EV/EBITDA

Enterprise value stands at -0.82 times EBITDA. This is generally considered low.

-0.82

How Well Does MRAI Make Money?

Net Profit Margin

For every $100 in sales, Marpai, Inc. keeps $-97.37 as profit after all expenses.

-97.37%

Operating Margin

Core operations generate -80.40 in profit for every $100 in revenue, before interest and taxes.

-80.40%

ROE

Management delivers $49.95 in profit for every $100 of shareholder equity.

49.95%

ROA

Marpai, Inc. generates $-1.53 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.53%

Following the Money - Real Cash Generation

Operating Cash Flow

Marpai, Inc. generates limited operating cash flow of $-5.50M, signaling weaker underlying cash strength.

$-5.50M

Free Cash Flow

Marpai, Inc. generates weak or negative free cash flow of $-5.50M, restricting financial flexibility.

$-5.50M

FCF Per Share

Each share generates $-0.32 in free cash annually.

$-0.32

FCF Yield

MRAI converts -78.93% of its market value into free cash.

-78.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.98

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.67

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.38

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.50

vs 25 benchmark

ROA

Return on assets percentage

-1.53

vs 25 benchmark

ROCE

Return on capital employed

0.85

vs 25 benchmark

How MRAI Stacks Against Its Sector Peers

MetricMRAI ValueSector AveragePerformance
P/E Ratio-0.9829.20 Better (Cheaper)
ROE49.95%729.00% Weak
Net Margin-97.37%-52856.00% (disorted) Weak
Debt/Equity-0.020.49 Strong (Low Leverage)
Current Ratio0.384.43 Weak Liquidity
ROA-152.76%-20711.00% (disorted) Weak

MRAI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Marpai, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-8.65%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-10.75%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ